BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Cell Therapy
    • COVID-19
    • CAR-T
    • Cord Blood
  • Exosomes
  • Interviews
  • News
    • Press Releases
    • Job Posts
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » Diversifying Cord Blood Banking through Adipose-Derived Stem Cell Storage
4 Key Definitions that Will Improve Market Research for the Stem Cell Biobanking Market

Diversifying Cord Blood Banking through Adipose-Derived Stem Cell Storage

August 1, 2020 By Cade Hildreth (CEO)

The global cord blood banking industry has been rapidly maturing in recent years. In part, this has been caused by changes in processing, storage, and transplantation technologies. These changes require executives and industry decision-makers to have a firm understanding of emerging trends.

Discover class-defining bioproduction tools.

One of the most notable cord blood industry trends has been a diversification of services. Put simply, cord blood banks are becoming diversified stem cell biobanks.

Cord blood banks worldwide have started to incorporate the storage of:

  • umbilical cord tissue
  • placental blood and tissue
  • amniotic fluid
  • menstrual fluid
  • dental pulp stem cells
  • adipose tissue
  • peripheral blood

Because cord blood banking is a niche service, there are several benefits to diversifying into related areas of stem cell storage. These include but are not limited to increased revenue, diversification, up-selling / cross-marketing opportunities, and cost efficiencies.

American Cryostem, an Adipose-Derived Stem Cell Storage Company

American Cryostem is an American-based company that offers cord blood banks the opportunity to license their proprietary adipose-derived stem cell technologies.

RoosterCollect EV Pro

Specifically, they  allow companies to license their adipose-derived stem cell :

  • processing technologies
  • storage platform technologies
  • expansion and differentiation services
  • marketing materials

This allows third-party partners (cord blood banks) to quickly and cost-effectively integrate this service.

Importantly, American Cryostem grants only one exclusive license per region. Thus, if a license is available for your region, a partnership of this nature could be an efficient way to add adipose-tissue storage as a “bolt-on” service.

To learn more about emerging trends and opportunities, view the “Global Cord Blood Banking Industry Report 2020.”Cord Blood Market Report 2020

About BioInformant

BioInformant is the first and only market research firm to specialize in the stem cell industry. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Xconomy, and Vogue Magazine. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry data.

5 / 5 ( 4 votes )

Filed Under: Adipose SCs, Cord Blood, MSCs Tagged With: adipose-derived stem cells, American Cryostem, biobanking, stem cells

Related

About Cade Hildreth (CEO)

Cade Hildreth is the Founder of BioInformant.com, the world's largest publisher of stem cell industry news. Cade is a media expert on stem cells, recently interviewed by the Wall Street Journal, Los Angeles Business Journal, Xconomy, and Vogue Magazine. 

Comments

  1. David Chen says

    March 14, 2015 at 12:29 pm

    I am running a anti-aging clinic with fat derived stem cells for facial and intravenous injection. I am in Los angeles.
    I would like to know about storage.

    I also like to do peripheral blood storage and application

    Could you give some advise

    Dr. Chen.

Let’s Get Social

  • Facebook
  • Twitter
  • Instagram
  • Pinterest
  • LinkedIn

Nanocellect

Marathon Products

Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Featured Posts

Stem cell conferences

The Complete Guide To Virtual Stem Cell Conferences in 2021

CO.DON AG

The New CO.DON Plant for the EU-approved Advanced Therapy Cartilage Regeneration Treatment Sets a Milestone in Cell Therapy for Commercial Manufacturing

Safety Chart | The Future of Stem Cell Therapeutics – Balancing Safety and Efficacy

The Future of Stem Cell Therapeutics – Balancing Safety and Efficacy

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2021 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.